Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer

ObjectiveEmerging evidence showed that immune checkpoint inhibitors (ICIs) lead to hyperprogressive disease (HPD) in a small proportion of patients. There is no well-recognized standard for the evaluation of HPD. Comprehensive exploration of HPD definition system in gastrointestinal cancer treated w...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenghang Wang, Chang Liu, Yuezong Bai, Xiaochen Zhao, Longgang Cui, Zhi Peng, Xiaotian Zhang, Xicheng Wang, Zhengyi Zhao, Jian Li, Lin Shen
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
hyperprogressive disease
gastrointestinal cancer
immune checkpoint inhibitors
circulating tumor DNA
next-generation sequencing
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/dc2063dc3e28419fbe5a61234b8e96fb
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/dc2063dc3e28419fbe5a61234b8e96fb

Similar Items